REMAX (RMAX) Q2 EPS Beats by 8%

RE/MAX Holdings reported mixed Q2 2025 results, with Non-GAAP EPS of $0.39 beating estimates due to cost discipline, which also improved Adjusted EBITDA margin to 36.1%. However, GAAP revenue declined 7.3% year-over-year to $72.8 million, missing forecasts, primarily due to continued contraction in U.S. and Canadian agent counts (U.S. down 7%). While global agent count reached a record high of 147,073, driven by international growth, the company revised its full-year 2025 revenue and Adjusted EBITDA guidance downwards, reflecting ongoing challenges in its core North American business despite operational efficiencies.

Analysis

RE/MAX Holdings (RMAX) presented a mixed financial profile for Q2 2025, characterized by effective cost management but persistent top-line pressure in its core markets. The company surpassed Non-GAAP EPS estimates with $0.39 versus a $0.36 consensus, a result driven by a 5.7% year-over-year reduction in operating expenses which also lifted the Adjusted EBITDA margin to 36.1%. However, this profitability was overshadowed by a 7.3% YoY decline in GAAP revenue to $72.8 million, which missed analyst expectations. The revenue shortfall is directly attributable to ongoing weakness in North America, where U.S. agent count contracted by a significant 7% and Canadian count fell 0.9%. This core market deterioration drove declines across key revenue streams, including a 4.7% drop in recurring franchise fees and a 7.4% fall in broker fees. While the company achieved a record global agent count of 147,073, this was fueled entirely by an 11.5% increase in international agents, which has not been sufficient to offset the North American decline. Management's cautious outlook, evidenced by downward revisions to full-year 2025 guidance for both revenue and Adjusted EBITDA, alongside a sharp decrease in year-to-date adjusted free cash flow, underscores the material impact of these headwinds.

Key Decisions for Investors

• Investors should closely monitor U.S. and Canadian agent count trends in the upcoming quarters, as stabilization in these figures is a critical prerequisite for a revenue turnaround.
• Evaluate the effectiveness of strategic initiatives like the BoldTrail platform and ASPIRE program by tracking agent productivity metrics and retention rates in subsequent reports to validate their long-term value proposition.
• Given the downward revision to full-year guidance and a significant H1 2025 decline in free cash flow, a cautious or neutral stance may be warranted until there are clear signs of recovery in the North American housing market or franchise sales.
• The bifurcation between strong international agent growth and severe domestic contraction suggests investors should weigh the potential for global expansion against the ongoing margin and revenue pressures from the core U.S. business.